We are committed to confronting climate change and challenging ourselves to meet ambitious environmental goals. 76% renewable electricity, on track for our goal of 100% by 2024. 40% of energy from renewable sources, on track for our goal of 90% by 2027. SBTi approval Net-zero and greenhouse gas emission reduction targets approved by the Science Based Targets initiative (SBTi)We are dedicated to investing in our people so that together, we can impact global health disparities – breaking down barriers to improve patient lives. 42.6% of supervisor and manager roles held by women globally. 22.6% by multicultural employees in the U.S., including Puerto Rico. 99% pay equityEthics and integrity govern the work we do every day – we conduct business in a way that respects human life and enables us to make products that people trust. ~37 million products delivered. 97% effectiveness in corrective and preventive action (CAPA) metrics and 99% on-time approvals. 0 findings resulting in action following more than 325 external audit daysBoston Scientific specializes in medical devices for various medical procedures. Its broad portfolio and commitment to innovation contribute to its financial stability. The company generates revenue from the sale of medical devices used in procedures such as cardiac interventions and endoscopy. Boston Scientific’s ongoing innovation ensures it remains a key player in medical device markets, impacting both its revenue and industry progress.At Boston Scientific, our environmental, social and governance (ESG) strategy is at the core of how we maximize value for our stakeholders. We carry out our strategy through ethical, sustainable and inclusive practices that enable business growth and achieve results